Swedish life science strategy needs to be fleshed out

According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments.

However, it believes that, in order to succeed, the strategy needs to be supplemented with the necessary connection to the fact that new medicines and innovations need to be used early in healthcare.

The government's life science strategy is a long-term framework that sets goals for how the sector can develop and Sweden become a leader in life science in Europe. The fact that Sweden has an established office for life science in the government and a national strategy provides good conditions in the direction of this overall goal. At the same time, the strategy includes many objectives within a number of different policy areas, and Lif wants to emphasize the importance of making the objectives concrete via special government investments, legislative proposals or other rule changes.